Dr. Benjamin Ted Alwood, MD

Dr. Alwood practices at Brooks Rehabilitation in Jacksonville, Florida.

Dr. Alwood's NPI, 1841780798, was assigned on May 16, 2018. Dr. Alwood graduated from Ross University School of Medicine in 2018. Dr. Alwood holds Florida license ME161573.

Dr. Alwood's primary practice is Brooks Rehabilitation, at 3599 University S Blvd, Jacksonville, FL 32216 in Duval County. The practice phone is (904) 345-7607.

Dr. Alwood's primary practice is Brooks Rehabilitation in Jacksonville, Florida. Dr. Alwood is also affiliated with UF Health Jacksonville. The medical group on file is UF Jacksonville Physicians, Inc. Dmand AI also links Dr. Alwood to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alwood practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Alwood's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Alwood is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Alwood's licenses on file in 3 states: Florida, California and Virginia.

Dmand AI lists cerebrovascular disease, lower back pain and seizures among the conditions Dr. Alwood treats.

CMS data shows 381 Medicare services from Dr. Alwood across 7 procedure codes in 2024, for 249 Medicare patients. Medicare paid $24,594 for them.

CMS counts 249 Medicare patients who saw Dr. Alwood in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alwood's median patient age at 74, with 53% women.

In 2024, Dr. Alwood wrote 489 Medicare Part D claims for 119 patients. 90% of them were for generic drugs. CMS names the drug for 298 of them, across 13 drugs with 11 or more claims each, at $2,969 in total drug cost. In 2022, CMS named 35 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 60 out of 100 for Dr. Alwood for performance year 2024, reported through an alternative payment model (APM). Dr. Alwood accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alwood as offering telehealth.

Dmand AI links 4 papers to Dr. Alwood, published from 2023 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Stroke. Dr. Alwood has published most often in J Stroke Cerebrovasc Dis. Dr. Alwood's most frequent co-authors are Brett Cowan Meyer, MD, Briana Moore Poynor, MD and Dolores Torres, MD.

Dmand AI links Dr. Alwood to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Ischemic Stroke, Cerebral Hemorrhage and Intracranial Hemorrhages.

CMS Open Payments shows 4 general payments to Dr. Alwood from 3 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 89% of the total. AstraZeneca Pharmaceuticals LP paid the most, $113.

Dr. Alwood graduated from Ross University School of Medicine in 2018.

Dr. Alwood is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.